Express Scripts, a subsidiary of Cigna, has not terminated business relationships due to ideological beliefs. Express Scripts has not used corporate dollars to advance non-business interests. However, Express Scripts operates under Cigna's hiring policy, which will not hire people based on certain "privileges." Express Scripts does not have viewpoint protections for its employees. Cigna has also supported the Equality Act. For these reasons, Express Scripts receives a "Medium Risk" rating.
Has denied service to customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
There are no publicly known cases of Express Scripts terminating business relationships due to religious or political views. However, Express Scripts’ parent company, Cigna, avoids hiring people if they are not diverse enough based on the company’s wide-ranging privilege scale that includes race and religion (1).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Express Scripts’ gift matching program is operated through Cigna, which does not discriminate against faith-based charities (1).
Employment policies fail to protect against discrimination based on political affiliation/views and/or religion.
Express Scripts does not protect employees from viewpoint discrimination (1).
Uses corporate reputation to support ideological causes and/or organizations hostile to freedom of expression.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
There are no publicly known cases of Express Scripts using corporate funds to advance ideological causes.
Uses corporate political contributions for ideological, non-business purposes.
Express Scripts’ PAC giving is operated by Cigna, which has not used its PAC for ideological purposes (1).
All links were last accessed and all information was updated on:
December 26, 2022
Company reports are intended for educational use only. Full Disclaimer